Benznidazole and nifurtimox are the only antimicrobial<unk> es with proven efficacy against T. cruzi infection. Neither drug is FDA-approved, but can be obtained under investigational protocol. Either benznidazole or nifurtimox may be used to manage congenital infection, acute infection, and chronic infection (only among young patients < 50-55 years) including those with early cardiomyopathy.
Chagas disease medical therapy
Babesiosis medical therapy
Psittacosis medical therapy
Enterobiasis medical therapy
Listeriosis medical therapy
Kyphosis medical therapy
Strongyloidiasis medical therapy
Yaws medical therapy